DirecTV on Sunday unveiled a new feature that allows its satellite customers to opt out of receiving local stations. The plan ...

To promote the ability for consumers to access DirecTV without a satellite dish, the effort turns dishes into bird sanctuaries in a nod to the iconic moment when Johnson accidentally killed a bird ...

FREE TV PROGRAMMING: The antenna allows you to watch free TV programming without having to subscribe to cable or satellite TV. This can save you a lot of money in the long run. The antenna can ...

Trey Paul is a CNET senior editor covering broadband. His 20+ years of experience as a writer and editor include time at CNET's sister site, Allconnect, and working with clients like Yahoo!

Hall Communications Lakeland Chief Engineer Steve Tuzeneu said his satellite dish needed attention, so he turned to Linkup Communications President Mark Johnson for tips on repainting the dish. Mark ...

A satellite dish is then installed on the exterior of your home free from any obstructions like trees or buildings so your satellite dish can receive the signal from space after your internet ...

(BMJ Open) Reboxetine -- a norepinephrine reuptake inhibitor and cortical dopamine modulator -- significantly reduced cataplexy attacks compared with placebo in the 5-week phase III SYMPHONY trial ...

Aquestive Therapeutics has achieved positive Phase III data for their Anaphylm epinephrine sublingual film, showing comparable efficacy to auto-injectors. The company is moving forward with plans ...

Palvella Therapeutics has partnered with Ligand Pharmaceuticals for the Phase III clinical trial investigating topical Qtorin rapamycin for the treatment of microcystic lymphatic malformations.

Vertex Pharmaceuticals Inc. is acquiring Alpine Immune Sciences Inc. for $4.9 billion in cash to gain Alpine’s lead product, phase III-ready povetacicept, which demonstrates best-in-class potential in ...

(RTTNews) - GSK plc. (GSK, GSK.L) announced positive results from the pivotal EAGLE-1 phase III trial for gepotidacin, a potential first-in-class oral antibiotic with a novel mechanism of action ...

Based on this successful outcome, IRLAB will now move forward with the preparations of the Phase III program. At the End-of-Phase 2 meeting with the FDA, aspects related to all parts of the ...